z-logo
open-access-imgOpen Access
Mitochondria, Cognitive Impairment, and Alzheimer's Disease
Author(s) -
Mariateresa Mancuso,
Valeria Calsolaro,
Daniele Orsucci,
Cecilia Carlesi,
Anna Choub,
Selina Piazza,
Gabriele Siciliano
Publication year - 2009
Publication title -
international journal of alzheimer s disease
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.657
H-Index - 49
eISSN - 2090-8024
pISSN - 2090-0252
DOI - 10.4061/2009/951548
Subject(s) - mitochondrial dna , oxidative stress , neurodegeneration , haplogroup , mitochondrion , disease , dementia , biology , genetics , telomere , bioinformatics , neuroscience , medicine , gene , pathology , haplotype , allele , endocrinology
To date, the beta amyloid (Abeta) cascade hypothesis remains the main pathogenetic model of Alzheimer's disease (AD), but its role in the majority of sporadic AD cases is unclear. The "mitochondrial cascade hypothesis" could explain many of the biochemical, genetic, and pathological features of sporadic AD. Somatic mutations in mitochondrial DNA (mtDNA) could cause energy failure, increased oxidative stress, and accumulation of Abeta, which in a vicious cycle reinforce the mtDNA damage and the oxidative stress. Despite the evidence of mitochondrial dysfunction in AD, no causative mutations in the mtDNA have been detected so far. Indeed, results of studies on the role of mtDNA haplogroups in AD are controversial. In this review we discuss the role of the mitochondria, and especially of the mtDNA, in the cascade of events leading to neurodegeneration, dementia, and AD.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom